Browse by Day Archive

HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug

09/02/2026 11:47pm
GSK subsidiary GlaxoSmithKline Intellectual Property (No. 4) Ltd will pay ​a unit of HUTCHMED (China) $110 million upfront for rights to an experimental drug for solid tumours, ‌the Chinese drugmaker said on Thursday.

Nestle to build infant formula plant in Brazil as part of $393 million investment

09/02/2026 9:03pm
Nestle will invest ​2 billion reais ($392.73 million) in its nutrition and health division in Brazil through ‌2028, including 600 million reais for a new infant ⁠formula factory in Minas ​Gerais state, the ⁠company said on Thursday.

Ultragenyx's rare disease drug fails in late-stage trial; shares plunge

09/02/2026 2:19pm
Ultragenyx Pharmaceutical said on Wednesday its experimental drug for a ​rare genetic neurodevelopmental disorder did not meet the main goal in a late-stage trial, sending its shares down 45% in ‌aftermarket trading.

Novartis signs deal worth up to $3.2 billion for Alteogen's drug delivery technology

09/02/2026 6:12am
South Korea's Alteogen said on Wednesday it has ​signed a deal with Novartis worth up to $3.22 billion, giving the Swiss drugmaker ‌access to its technology to make injectable versions of intravenous ⁠drugs.

Bayer says Crop Science unit makes progress on product launches

09/02/2026 6:05am
Bayer said on Wednesday its Crop ​Science business had introduced two out of 10 planned new products ‌with peak annual sales of at least €500 million ($579 ⁠million) each and ​mapped out further ⁠market launches.

Owkin signs AI drug discovery deal with Boehringer for cancer, immunology

09/02/2026 6:03am
AI company Owkin said on ​Wednesday it has signed a licensing deal with Germany's Boehringer Ingelheim, giving the ‌drugmaker access to its AI research platform and patient ⁠data to speed ​up discovery of ⁠drugs for cancer and immunity-related diseases.

Teva's immune disorder drug meets main goal in mid-stage trial

09/02/2026 6:03am
Israeli drugmaker Teva Pharmaceutical Industries, said on Wednesday its experimental drug helped ​prevent gluten-related intestinal damage in adults with celiac disease, meeting the main goal of a mid-stage trial.

Aspen bets on manufacturing rebound, obesity drug push for growth

09/02/2026 5:25am
Aspen Pharmacare forecast strong double-digit earnings growth for fiscal 2027 on Wednesday, as the ​South African drugmaker bet on a sharp recovery in its manufacturing business and the global rollout of its generic weight-loss medicines.

Health Rounds: Scientists find genes linked to OCD, raising the prospect of new treatments

09/02/2026 5:23am
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays)

Congo's Ebola outbreak kills more than 3,000, government figures show

09/02/2026 2:00am
The number of deaths in Democratic Republic of Congo's Ebola ​outbreak has surpassed 3,000, government data showed on Wednesday, as the country's worst-ever epidemic continues to spread across its ‌northeast.